Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Overall Survival With the Addition of Ribociclib to Endocrine Therapy in Advanced HR-Positive, HER2-Negative Breast Cancer – The ASCO Post (free)
Join our WhatsApp group
Free Updates in All Specialties!
A daily update on the latest medical news, practice-changing trials and guidelines
TOP 10 Medical News Stories